glp 1 peptide GLP-1 (C/S) PDB-101: Molecule of the Month:

Nat Microbiol

While autoinjectors have streamlined the process, a learning curve remains, and discomfort persists for many

Why does weight loss plateau, and what happens when you quit

Other observational studies have linked GLP-1 drugs to lower rates of new and recurring alcohol use disorder, reduced diagnoses and relapse in cannabis use disorder, fewer health care visits for nicotine dependence and lower risk of opioid overdose

At 48 weeks, the mean relative change from baseline in liver fat was 51.3% (1 mg), 59.0% (4 mg), 81.7% (8 mg), 86.0% (12 mg), and 4.6% (placebo)

The question of GLP-1 use during breastfeeding has specific considerations that require medical consultation